ERBB2 and neoplasm: We also collected tumor staging (I-IV or TNM), receptor status (ER/PR/HER2), initial treatment and outcome, recurrence or progression, survival or follow-up status, and whether the authors attributed any aspect of the delay or complexity to the patient’s obesity.